Effect of roflumilast on lung function and exacerbations in patients with chronic obstructive pulmonary disease: Results of a one year study

被引：0
|
作者：
Calverley, PMA
Fabbri, LM
Teichmann, P
Bredenbroeker, D
机构：
[1] Univ Hosp Aintree, Liverpool, Merseyside, England
[2] Univ Modena, I-41100 Modena, Italy
[3] ALTANA Pharma AG, Constance, Germany
来源：
THORAX | 2005年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：II42 / II42
页数：1
相关论文
共 50 条
  • [41] Effect of Zafirlukast on lung function improvement in patients with Chronic obstructive pulmonary disease (COPD)
    Mostafapour, E.
    Javad, Mousavi Seyed Ali
    Seyed-Mohammad, Fereshtehnejad
    Shahab, Shahabi
    Baharak, Tasorian
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 97 - 98
  • [42] Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
    Kim, Kyung Hoon
    Kang, Hye Seon
    Kim, Ju Sang
    Yoon, Hyoung Kyu
    Kim, Sung Kyoung
    Rhee, Chin Kook
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3449 - 3456
  • [43] Duration of Hospitalization and Lung Function Deterioration as Predictors of Future Chronic Obstructive Pulmonary Disease Exacerbations
    Papaioannou, Andriana I.
    Bartziokas, Konstantinos
    Papiris, Spyros
    Loukides, Stelios
    Kostikas, Konstantinos
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (06) : 698 - 700
  • [44] Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
    Molimard, M.
    Blin, P.
    Maleyran, S. Lignot
    Lassalle, R.
    Lamarque, S.
    Bernard, M. A.
    Demeaux, J. L.
    Guillemot, D.
    Housset, B.
    Mayaud, C.
    Peyramond, D.
    Pouchain, D.
    Moore, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 7 - 7
  • [45] Management of chronic obstructive pulmonary disease (COPD) exacerbations: Results of a French cohort study
    Blin, P.
    Lignot, S.
    Lamarque, S.
    Lassalle, R.
    Bernard, M-A
    Guillemot, D.
    Mayaud, C.
    Moore, N.
    Molimard, M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S184 - S185
  • [46] Chronic obstructive pulmonary disease .6: The aetiology of exacerbations of chronic obstructive pulmonary disease
    White, AJ
    Gompertz, S
    Stockley, RA
    THORAX, 2003, 58 (01) : 73 - 80
  • [47] Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease
    Stevenson, NJ
    Walker, PP
    Costello, RW
    Calverley, PMA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) : 1510 - 1516
  • [48] Randomized Double-Blind Controlled Trial of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    Mackay, Alex J.
    Patel, Anant R. C.
    Singh, Richa
    Sapsford, Raymond J.
    Donaldson, Gavin C.
    Prasad, Niyati
    Goehring, Udo-Michael
    Nip, Tsz Keung
    Wedzicha, Jadwiga A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (05) : 656 - 659
  • [49] Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
    Niewoehner, DE
    Erbland, ML
    Deupree, RH
    Collins, D
    Gross, NJ
    Light, RW
    Anderson, P
    Morgan, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25): : 1941 - 1947
  • [50] The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease
    van Rijn, Anneloes L.
    van Boheemen, Sander
    Sidorov, Igor
    Carbo, Ellen C.
    Pappas, Nikos
    Mei, Hailiang
    Feltkamp, Mariet
    Aanerud, Marianne
    Bakke, Per
    Claas, Eric C. J.
    Eagan, Tomas M.
    Hiemstra, Pieter S.
    Kroes, Aloys C. M.
    de Vries, Jutte J. C.
    PLOS ONE, 2019, 14 (10):
12345